Wordt geladen...
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer
Until recently, there had not been an effective systemic chemotherapy for advanced differentiated thyroid carcinoma (DTC); lenvatinib, a multi-tyrosine kinase inhibitor, has been proven effective for DTC, but has also been revealed to have adverse side effects including hypertension, hand-foot syndr...
Bewaard in:
| Gepubliceerd in: | Mol Clin Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492816/ https://ncbi.nlm.nih.gov/pubmed/28685069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1265 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|